Several hematologic markers, including serum β2-microglobulin (β2M) [9, 11, 12], albumin [13, 14] and components derived from baseline complete blood cell counts [11, 15–20] have been proved to be of prognostic value in DLBCL. Here, B2M is linked to diffuse large B-cell lymphoma.